Diabetes

Featured Article

Clinician Perspective: Examining the Link Between Antipsychotics and Diabetes

Clinician Perspective: Examining the Link Between Antipsychotics and Diabetes

Endocrinologist Kevin M. Pantalone, DO, and psychiatrist Christian Kohler, MD, discuss the risk associated with the use of antipsychotic medications in individuals with type 2 diabetes.

Latest

Impact of Maternal Diabetes on Outcomes in Very Preterm, Very Low-Birth-Weight Infants

Impact of Maternal Diabetes on Outcomes in Very Preterm, Very Low-Birth-Weight Infants

A retrospective cohort study was conducted to assess the relationship between maternal diabetes and morbidity/mortality in preterm infants.

Popliteal Sciatic Nerve Block May Increase Time to First Opioid Request in Diabetic Peripheral Neuropathy

Popliteal Sciatic Nerve Block May Increase Time to First Opioid Request in Diabetic Peripheral Neuropathy

Patients with type 2 diabetes and diabetic peripheral neuropathy may have an increased time to first opioid request and reduced time to onset of sensory blockade after an ultrasound-guided popliteal sciatic nerve block compared with patients without neuropathy.

Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes

Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes

A retrospective, observational study was conducted to assess outcomes in patients with type 2 diabetes treated with second-generation basal insulin analogs.

Travel Costs Are Considerable Part of T2DM Follow-Up Costs

Travel Costs Are Considerable Part of T2DM Follow-Up Costs

For patients with type 2 diabetes mellitus (T2DM), travel costs relating to hemoglobin A1c (HbA1c) screening constitute a substantial cost item, and self-monitoring can reduce costs.

Link Between Oral Diabetes Medications and Bullous Pemphigoid

Link Between Oral Diabetes Medications and Bullous Pemphigoid

Finnish investigators evaluated the link between diabetes medications other than DPP-4 inhibitors and the risk for BP.

Calcium Channel Blocker May Benefit Patients With Type 1 Diabetes

Calcium Channel Blocker May Benefit Patients With Type 1 Diabetes

For this study, researchers conducted a randomized, double-blind, placebo-controlled Phase 2 trial (N=24) to assess the efficacy and safety of adding oral verapamil for 12 months to a standard insulin regimen in adults with recent-onset type 1 diabetes (age range: 18 to 45 years).

β-Cell Function in Youth With Impaired Glucose Tolerance, T2D

β-Cell Function in Youth With Impaired Glucose Tolerance, T2D

Investigators examined whether β-cell function can be improved or preserved with antihyperglycemic agents in young patients.

1996 to 2013 Saw Large Increase in Diabetes Spending

1996 to 2013 Saw Large Increase in Diabetes Spending

Increased spending per encounter has been the biggest driver of overall rise in spending.

Oral Insulin Choline, Geranate Ionic Liquid Shows Promise

Oral Insulin Choline, Geranate Ionic Liquid Shows Promise

Significant, sustained decrease in blood glucose levels with low insulin doses of 3 to 10 U/kg.

Assessment of Low-Dose Aspirin As Chemoprevention in Type 2 Diabetes

Assessment of Low-Dose Aspirin As Chemoprevention in Type 2 Diabetes

Investigators examined the efficacy of low-dose aspirin in cancer chemoprevention in patients with diabetes.

Sign Up for Free e-Newsletters



CME Focus